June 05, 2022
1 min watch
[ad_1]
Source/Disclosures
Published by:
Source:
Healio Interviews
Disclosures:
Gavin reports receiving consulting fees from Abbott, Medtronic and Novo Nordisk. Peters reports participating on advisory boards for Abbott Diabetes Care, AstraZeneca, Eli Lilly, Medscape, Novo Nordisk and Zealand; receiving research support from Dexcom, Insulet and donated devices from Abbott Diabetes Care; and holding stock options with Omada Health and Teladoc.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
SAN DIEGO — In part one of this video exclusive, James R. Gavin III, MD, PhD, talks with Anne L. Peters, MD, about using technology in underserved populations to close the diabetes treatment gap.
Gavin is clinical professor of medicine at Emory University and chief medical officer of Healing Our Village. He is a Healio | Endocrine Today Co-Editor. Peters is professor of clinical medicine at Keck School of Medicine of the University of Southern California and an Endocrine Today Editorial Board Member. She has clinical practices in both underserved East Los Angeles and the well-resourced westside.
Gavin and Peters discuss how diabetes technology has widened health inequities — from insurance inequities and paperwork to basic social insecurity, lack of experience with any technology and limited knowledge of diabetes self-care.
“And yet we’ve shown in our research that if I give [under-resourced patients] the tools and the education, I can improve their outcomes just like anybody else,” Peters said.
Peters describes how she has addressed these issues over more than 20 years in practice.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
American Diabetes Association Scientific Sessions
[ad_2]
Source link
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
Related Posts
Florida Reports First 2026 Death Linked to Vibrio vulnificus as Cases Rise to 12
- FYH News Team
Nationwide Levothyroxine Recall: Patients Urged to Check Thyroid Medication Lots
- Subash Kafle
R&B Singer Nivea Reveals Leukemia Diagnosis at 44, Says Treatment Is Going Well
- Subash Kafle
